tirzepatide news october 2025 Eli Lilly becomes the first pharmaceutical company to join the trillion-dollar club FDA Says Shortage of GLP-1

Cost and Coverage of Ozempic and Wegovy in Ontario Heres the reality: neither medication is cheap

EdwardsBirminghamAlabama$1M$561M$2-100M$4-10MDanny HottelHottel Capital | Northwestern MutualBirminghamAlabama$6M$475M$1.5-60M$2-48MCharlie NorwoodMorgan Stanley Wealth ManagementBirminghamAlabama$2M$3.4B$5-10M$2-5MJeff RobertsAmeriprise Financial ServicesBirminghamAlabama$250K$1B$2-10M$250K-10MPaul RussellMorgan Stanley Wealth ManagementMobileAlabama$500K$1B$2-8M$1-4MMatthew LairdRaymond James & AssociatesBirminghamAlabama$500K$821M$1-2.5M$750K-3MDavid StaleyMerrill Wealth ManagementHuntsvilleAlabama$500K$629M$2-5M$1-3MAmanda RaneyMorgan Stanley Wealth ManagementBirminghamAlabama$1M$664M$3-15M$1-10MParker HuddleMerrill Wealth ManagementMobileAlabama$250K$455M$2-5M$1.5-3MLuis GarciaRaymond James & AssociatesHuntsvilleAlabama$2M$3B$5-250M$2-155MTodd LowryMorgan Stanley Wealth ManagementHuntsvilleAlabama$600K$1.4B$1-10M$1-1.2MDrew GreenwaldEdward JonesAndalusiaAlabama$500K$347M$750K-5M$400K-2.5MTod FrickMorgan Stanley Wealth ManagementFairhopeAlabama$1M$893M$1.5-7M$1-6MMelanie NicholsWaverly AdvisorsBirminghamAlabama$1M$18.2B$2-25M$1-10MProfile SpotlightShaun CosbyMorgan Stanley Wealth ManagementBirminghamAlabama$500K$616M$2-10M$10-15MJordan PlasterAmeriprise Financial ServicesTuscaloosaAlabama$800K$435M$2.5-20M$1-10MTrip PhillipsMeridiem Advisory Group | Raymond JamesMontgomeryAlabama$250K$1.3B$3-20M$1-10MChuck AndrewsPatterson Andrews Wealth Management | Northwestern MutualHooverAlabama$500K$744M$2.5-15M$1-5MJason SchrimsherUBS Wealth ManagementHuntsvilleAlabama$250K$523M$1-5M$500K-1.5MJohn Parker WilsonMorgan Stanley Wealth ManagementBirminghamAlabama$5M$2.4B$20-100M$10-100MJeff EnglishMorgan Stanley Wealth ManagementBirminghamAlabama$250K$759M$1-2.5M$1-5MHutch RadcliffMorgan Stanley Wealth ManagementMobileAlabama$750K$1.2B$1-25M$500K-2MW

Fatigue typically resolves as the body adjusts to appetite changes and reduced caloric intake

Richards P, Parker HE, Adriaenssens AE, et al

A 31G or 32G needle is the most commonly recommended

Finally, maintain realistic expectations